Wnt and Beta-Catenin Signaling

The canonical Wnt pathway controls gene expression by regulating the stability of beta-catenin. Without a Wnt signal, beta-catenin is continuously degraded; when Wnt binds its receptors the degradation machinery is switched off, beta-catenin accumulates and enters the nucleus, where it partners with TCF/LEF factors to activate genes that govern development, stem-cell renewal, and tissue homeostasis.

Definition

Wnt/beta-catenin signalling is a pathway in which Wnt ligands binding Frizzled and LRP co-receptors inhibit a cytoplasmic destruction complex, allowing beta-catenin to escape degradation, accumulate, enter the nucleus, and act with TCF/LEF transcription factors to regulate target genes.

Scope

The entry covers the destruction complex that keeps beta-catenin low, how Wnt ligand binding inhibits it, the nuclear partnership with TCF/LEF transcription factors, and the consequences of dysregulation in development and cancer. It is reference material on mechanism, not clinical guidance.

Core questions

• How is beta-catenin kept low in the absence of a Wnt signal?
• How does Wnt binding switch the destruction complex off?
• How does the same protein serve both at cell-cell junctions and in transcription?
• Why do mutations that stabilise beta-catenin drive cancer?

Key concepts

• Beta-catenin destruction complex (APC, Axin, GSK-3beta)
• Frizzled and LRP5/6 co-receptors
• Regulated beta-catenin stability
• TCF/LEF DNA-binding partners
• Stem-cell maintenance and self-renewal
• APC loss and constitutive Wnt activation
• Dual structural and signalling roles of beta-catenin

Mechanisms

In the absence of Wnt, a destruction complex containing APC, Axin, and the kinase GSK-3beta phosphorylates beta-catenin and targets it for proteasomal degradation, keeping its level low. When Wnt binds Frizzled and the LRP5/6 co-receptor, the complex is recruited to the membrane and inhibited, so beta-catenin escapes degradation and accumulates. It then enters the nucleus and binds TCF/LEF transcription factors, converting them from repressors to activators of Wnt target genes (Clevers, 2006). The pathway is central to development, stem-cell renewal, and tissue homeostasis, and its disruption is a major driver of disease (Clevers & Nusse, 2012). Beta-catenin also has a separate structural role at adherens junctions, linking cadherins to the cytoskeleton, which is conceptually distinct from its transcriptional role (Halbleib & Nelson, 2006).

Clinical relevance

Mutations that inactivate APC or stabilise beta-catenin cause constitutive Wnt-target gene expression and are a hallmark of colorectal and other cancers, while the pathway's role in stem cells underlies its importance in tissue regeneration (Clevers & Nusse, 2012). This entry summarises those associations as background and does not provide diagnostic or treatment guidance.

Evidence & guidelines

The pathway rests on developmental-genetic and biochemical studies synthesised in major reviews and is reference science rather than the subject of clinical guidelines. The cited reviews represent the consensus mechanism and its disease links.

History

The pathway emerged from the convergence of cancer genetics, where the Wnt gene was found as a mouse mammary-tumour proto-oncogene, and developmental genetics in Drosophila, where its segment-polarity counterpart was characterised. Identification of beta-catenin, the destruction complex, and the TCF/LEF partners unified these strands into the canonical Wnt pathway.

Key figures

• Hans Clevers
• Roel Nusse
• Harold Varmus
• W. James Nelson

Seminal works

• clevers-2006
• clevers-2012

Frequently asked questions

Why is beta-catenin called a stability-controlled signal?

The signal does not change how much beta-catenin is made but how fast it is destroyed; turning the destruction off lets it build up and reach the nucleus, so its level is the readout of the pathway.

Does beta-catenin only act as a transcription factor partner?

No. Beta-catenin also has a structural role at cell-cell adherens junctions, linking cadherins to the cytoskeleton, which is separate from its role in Wnt-driven transcription.